TY - JOUR
T1 - Association between serum uric acid level and renal arteriolar hyalinization in individuals without chronic kidney disease
AU - Matsukuma, Yuta
AU - Masutani, Kosuke
AU - Tanaka, Shigeru
AU - tsuchimoto, akihiro
AU - Haruyama, Naoki
AU - Okabe, Yasuhiro
AU - Nakamura, Masafumi
AU - Tsuruya, Kazuhiko
AU - Kitazono, Takanari
N1 - Publisher Copyright:
© 2017 Elsevier B.V.
PY - 2017/11
Y1 - 2017/11
N2 - Background and aims Recent studies have reported an association between serum uric acid (SUA) and renal arteriolar changes in patients with chronic kidney disease (CKD). However, the association in individuals without CKD remains unclear. In this study, we investigated the relationship between SUA and renal arteriolar lesions in individuals without CKD from our living kidney donor cohort. Methods Between January 2006 and May 2016, 393 living kidney donors underwent “time-zero” biopsy at Kyushu University Hospital. Patients were divided into sex-specific quartiles of SUA before donation: Q1, Q2, Q3, and Q4 (male: <5.2,5.2–5.8,5.9–6.4, and ≥6.5 mg/dL, female: <3.8,3.8–4.3,4.4–5.0, and ≥5.1 mg/dL). Renal arteriolar hyalinization and wall thickening were assessed using a semiquantitative grading system. Predictive performance was compared between models with and without SUA by calculating the net reclassification improvement (NRI). Results In total, 158 (40.2%) patients had arteriolar hyalinization, and 148 (37.6%) had wall thickening. High SUA was significantly associated with arteriolar hyalinization in multivariable logistic analysis (odds ratio [OR] per 1-mg/dL increase in SUA, 1.24; 95% confidence interval [CI], 1.00–1.53; p = 0.048. OR for Q4 vs. Q2, 2.22; 95% CI, 1.17–4.21; p = 0.01). We found no association between SUA and wall thickening. When SUA was incorporated into a predictive model with conventional atherosclerotic factors, the NRI was 0.21 (p = 0.04). Conclusions High SUA was an independent risk factor for arteriolar hyalinization in individuals without CKD. SUA provided additional predictive value beyond conventional atherosclerotic factors in predicting arteriolar hyalinization.
AB - Background and aims Recent studies have reported an association between serum uric acid (SUA) and renal arteriolar changes in patients with chronic kidney disease (CKD). However, the association in individuals without CKD remains unclear. In this study, we investigated the relationship between SUA and renal arteriolar lesions in individuals without CKD from our living kidney donor cohort. Methods Between January 2006 and May 2016, 393 living kidney donors underwent “time-zero” biopsy at Kyushu University Hospital. Patients were divided into sex-specific quartiles of SUA before donation: Q1, Q2, Q3, and Q4 (male: <5.2,5.2–5.8,5.9–6.4, and ≥6.5 mg/dL, female: <3.8,3.8–4.3,4.4–5.0, and ≥5.1 mg/dL). Renal arteriolar hyalinization and wall thickening were assessed using a semiquantitative grading system. Predictive performance was compared between models with and without SUA by calculating the net reclassification improvement (NRI). Results In total, 158 (40.2%) patients had arteriolar hyalinization, and 148 (37.6%) had wall thickening. High SUA was significantly associated with arteriolar hyalinization in multivariable logistic analysis (odds ratio [OR] per 1-mg/dL increase in SUA, 1.24; 95% confidence interval [CI], 1.00–1.53; p = 0.048. OR for Q4 vs. Q2, 2.22; 95% CI, 1.17–4.21; p = 0.01). We found no association between SUA and wall thickening. When SUA was incorporated into a predictive model with conventional atherosclerotic factors, the NRI was 0.21 (p = 0.04). Conclusions High SUA was an independent risk factor for arteriolar hyalinization in individuals without CKD. SUA provided additional predictive value beyond conventional atherosclerotic factors in predicting arteriolar hyalinization.
UR - http://www.scopus.com/inward/record.url?scp=85030720009&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030720009&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2017.09.017
DO - 10.1016/j.atherosclerosis.2017.09.017
M3 - Article
C2 - 29024864
AN - SCOPUS:85030720009
SN - 0021-9150
VL - 266
SP - 121
EP - 127
JO - Atherosclerosis
JF - Atherosclerosis
ER -